New Zealand markets closed

Edwards Lifesciences Corporation (EW)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
85.94-0.51 (-0.59%)
At close: 04:00PM EDT
86.00 +0.06 (+0.07%)
After hours: 08:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 52.04B
Enterprise value 51.09B
Trailing P/E 37.59
Forward P/E 31.55
PEG ratio (5-yr expected) 4.97
Price/sales (ttm)8.77
Price/book (mrq)7.83
Enterprise value/revenue 8.51
Enterprise value/EBITDA 29.02

Trading information

Stock price history

Beta (5Y monthly) 1.07
52-week change 3-0.10%
S&P500 52-week change 321.23%
52-week high 396.12
52-week low 360.57
50-day moving average 389.95
200-day moving average 378.78

Share statistics

Avg vol (3-month) 34.03M
Avg vol (10-day) 32.78M
Shares outstanding 5601.93M
Implied shares outstanding 6601.93M
Float 8595.33M
% held by insiders 10.89%
% held by institutions 184.01%
Shares short (28 Mar 2024) 410.38M
Short ratio (28 Mar 2024) 42.57
Short % of float (28 Mar 2024) 41.74%
Short % of shares outstanding (28 Mar 2024) 41.73%
Shares short (prior month 29 Feb 2024) 48.44M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 301 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023


Profit margin 23.35%
Operating margin (ttm)39.40%

Management effectiveness

Return on assets (ttm)12.25%
Return on equity (ttm)22.34%

Income statement

Revenue (ttm)6B
Revenue per share (ttm)9.90
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
Net income avi to common (ttm)1.4B
Diluted EPS (ttm)2.30
Quarterly earnings growth (yoy)-7.20%

Balance sheet

Total cash (mrq)1.64B
Total cash per share (mrq)2.73
Total debt (mrq)694.9M
Total debt/equity (mrq)10.34%
Current ratio (mrq)3.38
Book value per share (mrq)11.06

Cash flow statement

Operating cash flow (ttm)895.8M
Levered free cash flow (ttm)751.03M